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Systems Biology has established numerous approaches for mechanistic modeling of molecular networks in the cell and a legacy of
models. The current frontier is the integration of models expressed in different formalisms to address the multi-scale biological
system organization challenge. We present MUFINS (MUlti-Formalism Interaction Network Simulator) software, implementing a
unique set of approaches for multi-formalism simulation of interaction networks. We extend the constraint-based modeling (CBM)
framework by incorporation of linear inhibition constraints, enabling for the ﬁrst time linear modeling of networks simultaneously
describing gene regulation, signaling and whole-cell metabolism at steady state. We present a use case where a logical hypergraph
model of a regulatory network is expressed by linear constraints and integrated with a Genome-Scale Metabolic Network (GSMN) of
mouse macrophage. We experimentally validate predictions, demonstrating application of our software in an iterative cycle of
hypothesis generation, validation and model reﬁnement. MUFINS incorporates an extended version of our Quasi-Steady State Petri
Net approach to integrate dynamic models with CBM, which we demonstrate through a dynamic model of cortisol signaling
integrated with the human Recon2 GSMN and a model of nutrient dynamics in physiological compartments. Finally, we implement
a number of methods for deriving metabolic states from ~omics data, including our new variant of the iMAT congruency approach.
We compare our approach with iMAT through the analysis of 262 individual tumor transcriptomes, recovering features of metabolic
reprogramming in cancer. The software provides graphics user interface with network visualization, which facilitates use by
researchers who are not experienced in coding and mathematical modeling environments.
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INTRODUCTION
During the last two decades, Systems Biology has established
numerous approaches to represent molecular biology knowledge
in the form of mechanistic molecular interaction network models.
This is accompanied by a legacy of thousands of experimentally
validated models. Stochastic kinetic simulations provide the most
detailed quantitative description, where individual reactive
collisions occurring at exact times in single cells are simulated
by the Gillespie algorithm.1 The Ordinary Differential Equation
(ODE) formalism applied to study the time evolution of average
molecular concentration in cellular population is a workhorse of
quantitative modeling.2 Although quantitative biology is devel-
oping rapidly, it is still not possible to parameterize quantitative
dynamic models of whole-cell scale networks and simulate
genotype–phenotype relationship. Rather, Constrained Based
Modeling (CBM) has achieved spectacular success in modeling
metabolism at the full genome scale.3,4 The metabolic network
can be modeled at quasi-steady state owing to timescale
separation from gene regulation. This enables exploration of
metabolic ﬂux distributions consistent with stoichiometric and
thermodynamic constraints as well as ﬂux measurements and
constraints formulated according to ~ omics data on enzymatic
gene expression.5 Modeling of large-scale gene regulatory and
signaling networks is much more challenging and a number of
qualitative simulation approaches have been formulated, such as
analysis of steady states in logical hypergraphs,6 enumeration of
states in dynamic Boolean models,7 Monte Carlo exploration of
the alternative molecular transition sequences constrained
by network connectivity expressed in Petri Net formalism.8,9
Application of these methods has led to a legacy of models
describing different levels of cellular organizations in different
modeling frameworks. A large proportion of these models are
already expressed in Systems Biology Markup Language (SBML)10
and over 1,000 literature-based models are available in the most
recent version of BioModels.11 Notably, BioModels is attracting
interest from the Physiologically Based Pharmacokinetic (PBPK)
modeling ﬁeld,12 where ODE models of substance concentrations
in physiological compartments are routinely used to inform drug
development in the pharmaceutical industry.
Given this state-of-the-art and the multi-scale nature of
biological systems, the current challenge is integration of models
expressed in different formalisms towards a multi-formalism
simulation covering all scales of biological organization. The
model of Mycoplasma is currently the most complete in silico
cell,13 and demonstrates that mechanistic modeling of the
genotype–phenotype relationship requires the integration of
subsystem models describing different spatial and temporal
scales constructed in different formalisms. The application of the
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multi-formalism approach toward modeling the relationship
between genotype and human physiology is an emerging ﬁeld
and an important component of the personalized medicine
challenge. For example, the integration of a PBPK model with
human liver-speciﬁc GSMN has allowed robust prediction of
therapeutic response in humans.14 In our recent work, we
integrated a liver-speciﬁc GSMN with a qualitative model of a
large-scale regulatory network,9 demonstrating how integration of
gene regulation and metabolism in the context of physiological
modeling can provide novel insights into toxicology, non-alcoholic
liver disease and metabolic syndrome. This was achieved by the
application of our novel Quasi-Steady State Petri Net (QSSPN)9
approach integrating CBM and qualitative, Monte Carlo simulation
of a regulatory network represented as a Signaling Petri Net.15
Numerous alternate methods have been proposed to integrate
GSMNs with ODE16 and logical17 dynamic models, as well as
hybrid algorithms, bridging the gap between exact stochastic and
ODE regimes in fully parameterized dynamic models.18 To fully
realize the potential of computational modeling, it is now
imperative to develop software packages that allow the develop-
ment and simulation of multi-formalism models in a user interface
that is approachable for experimental scientists.
Here, we present MUFINS (MUlti-Formalism Interaction Network
Simulator) software and argue that it is the ﬁrst general software
with Graphics User Interface (GUI) capable of integrating models
developed in all major modeling frameworks of Computational
Systems Biology. This is demonstrated through Use Cases; ﬁrst,
a model of the mammalian macrophage where linear inhibitory
constraints are for the ﬁrst time used to integrate a logical model
of cellular signaling with the GSMN for the mammalian cell;
second, a model of the human hepatocyte, where an extended
version of our QSSPN method is used to integrate a human GSMN,
a detailed kinetic model of cortisol signaling and a PBPK model;
third, the analysis of clinical transcriptome data in the context of
human GSMN using a novel variant of ~ omics data integration
approach. The Use Cases involve laboratory experiments to
demonstrate how experimental biologists can utilize the MUFINS
GUI in the iterative cycle of model development, hypothesis
generation, experimental validation and model reﬁnement.
Moreover, a comprehensive comparison with other software
shows that MUFINS implements the largest number of CBM
methods under a GUI with interactive network visualization. Thus,
MUFINS is uniquely suited for the development and simulation of
multi-formalism models by a wide user community including
experimental scientists with no/limited experience with program-
matic interfaces and mathematical modeling environments.
SOFTWARE OVERVIEW
Figure 1 provides an overview of the MUFINS architecture. All
simulations are performed in sfba and qsspn, two computational
engines written in C++, which are run either through a GUI or in
command line mode. The sfba code originates from our SurreyFBA
software19 and implements a comprehensive set of CBM
approaches. The major new multi-formalism simulation feature
added is linear inhibitor and activator constraints, which are
described and validated in Use Case 1. In addition to the basic
CBM methods available in SurreyFBA, the sfba engine of MUFINS
implements a large number of ~ omics data integration
algorithms such as iMAT,20 GIMME,20 GIM3E,21 GNI22 and our
DPA.23 The GNI and DPA features of sfba have been already
used to study Mycobacterium tuberculosis metabolism.23–25
Furthermore, we include Fast iMAT a new variant of iMAT
approach demonstrated in Use Case 3 below. sfba uses the
GLPK library for Linear Programming (LP) and Mixed Linear
Integer Programming (MILP) calculations. However, as MILP
implementation in GLPK is inefﬁcient, a version of sfba ready for
use with Gurobi library is provided to facilitate the application of
MILP-based protocols (e.g., iMAT) on GSMN models.
Figure 1. Overview of MUFINS. All the calculations are performed by two computational engines, which can be also run as stand-alone
command line tools. The sfba implements CBM methods and qsspn performs QSSPN simulations. JyMet is a graphic interface to all methods
providing spreadsheet representation of models and results as well as metabolic network visualization and plots. JyMet writes input ﬁles for
computational engines, starts calculations, imports output ﬁles and displays results. In the case of QSSPN simulations, Petri Net connectivity
can be graphically edited by Snoopy software, a standard Petri Net tool, which we use as external editor. JyMet imports Snoopy ﬁles and
provides spreadsheet interface allowing editing of QSSPN parameters or independent creation of entire QSSPN model. Conversion of Snoopy
ﬁles directly to qsspn engine is also possible with command line python script spept2qsspn. Both JyMet and Snoopy import and export SBML
ﬁle providing connectivity to other SBML-compliant tools. The ﬁle formats used for software component communication are indicated by
their default extensions and described in Supplementary File Formats. CBM, constraint-based modeling; MUFINS, MUlti-Formalism Interaction
Network Simulator; SBML, Systems Biology Markup Language; QSSPN, Quasi-Steady State Petri Net.
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The qsspn is a computational engine for integration of dynamic
and CBM models. It implements QSSPN approach,9 where a
dynamic model constructed in Petri Net (PN) formalism23 is
connected to a steady-state Flux Balance Analysis (FBA4) through
PN places setting FBA bounds and requesting evaluation of
objective functions. Previously, we integrated a qualitative PN
model with a hepatocyte GSMN and explored its qualitative
dynamic behaviors through Monte Carlo simulation.15 Here we
present a new version of the engine, providing full support for
continuous Petri Nets, implementing ODE models and stochastic
Petri Nets representing exact stochastic simulations. Use Case 2
demonstrates the ﬁrst integration of quantitative models of gene
regulation with human Recon2 GSMN coupled to an ODE model
of nutrients in physiological compartments. The qualitative
simulation features are also further extended by implementation
of QSSPNclient, a version of qsspn, which speeds up sampling of
alternative qualitative trajectories by executing FBA on a server
that tabulates repeated evaluations of GSMN objective functions
for re-occurring sets of bounds. The new version of the QSSPN
algorithm, qsspn solver and QSSPNclient are described in detail as
Supplementary Information (page 32).
Connectivity of a Petri Net representing the dynamical part of
the QSSPN model and its interactions with GSMN can be
graphically deﬁned using the Petri Net editor Snoopy:25 while
Snoopy provides PN simulation, it does not implement QSSPN and
thus is used here exclusively as an external editor of PN
connectivity. Parameters speciﬁc to qsspn simulation can be
provided either through the Comments section of place and
transition objects, or added later through the MUFINS GUI. The
Snoopy XML ﬁle is parsed by the spept2qsspn Python script, which
generates the qsspn input ﬁle in qsspn’s native, human readable,
text-ﬁle format. To facilitate future integration with other
interfaces, a JSON-based input ﬁle format is also available.
JyMet is the GUI of MUFINS, and provides an interface for
multi-formalism simulations to users who are not familiar with
programming, mathematical modeling environments or working
in command line. JyMet code is written in Jython (Java/Python),
and originates from SurreyFBA.19 Here, it has been signiﬁcantly
extended through addition of QSSPN simulation and improved
visualization of metabolic networks. JyMet integrates all elements
of the MUFINS environment (Figure 1). It loads a Snoopy ﬁle
deﬁning PN connectivity and provides a table interface for
deﬁnition of QSSPN speciﬁc parameters: place and transition
types, lookup tables linking dynamic and GSMN variables, and
arithmetic formulas describing complex rate laws. We note that
users can build dynamic model within the QSSPN spreadsheet
interface of JyMet without using Snoopy, but this is unlikely to be
a preferable solution, due to the advantages of PN graphical
modeling. Both sfba and qsspn can be run from JyMet and results
are loaded to spreadsheets and plotting functions. Each table in
JyMet can be exported in tab-separated format for further analysis
with other software. Full features of JyMet are described in detail
in software documentation and tutorials (MUFINS1.0_Doc/). Use
Case 1 shows application of network visualization for exploration
of alternative model solutions during the iterative cycle of
network reconstruction, simulation, experimental validation and
reﬁnement.
The sfba, qsspn and spept2qsspn tools can be run as stand-alone
command line tools without external dependencies. Thus MUFINS
is ideal for integration with web and desktop interfaces as well as
computational pipelines. Use Case 3 shows integration of sfba
engine with computational pipeline for analysis of clinical
transcriptome data. Previous version of sfba engine19 has been
already used in web interfaces supporting development and
publication of bacterial pathogen GSMN models26,27 and as one of
computational engines in METEXPLORE web environment.28
MUFINS is an open source software, distributed under the GNU
GPL license. It can be run on OS X, Windows and Linux sand the
majority of calculations can be run without dependencies.
The methods applying MILP to genome-scale models are likely
to be very computationally expensive unless the Gurobi library is
installed.
USE CASES
Table 1 summarizes Use Cases illustrating the multi-formalism
simulation abilities within MUFINS, including previously published
works.
Use Case 1: whole-cell metabolic reprogramming by signaling and
gene regulatory networks in the mammalian macrophage
An important innovation in MUFINS is the ability to include
stimulation and inhibition reactions within the genome-scale
metabolic network. To demonstrate the utility of this approach
to derive biological insights we present a use case entailing
integration of gene and signaling regulatory networks with
genome-scale metabolism for the mammalian macrophage.
We applied MUFINS to integrate a logical hypergraph6 model of
the large-scale regulatory network responsible for the pathogen
response of mammalian macrophage with the published GSMN
of the mouse RAW264.7 macrophage cell line.29 A signal
transduction network of 286 interactions and 205 species was
reconstructed in CellNetAnalyzer using logical hypergraph
formalism:6 A manually created graph image is shown in
Figure 2, with full description of model construction described
in Supplementary Information, and a detailed description
of species, logical formulas and literature references in
Supplementary Table 1. Brieﬂy, species within the regulatory
network represent protein kinases, transcription factors, genes,
antigens, cytokines and cellular behaviors (e.g., apoptosis)
involved in the response of macrophages to bacterial pathogens.
To integrate signaling and metabolic networks, we have
translated the logical hypergraph to a stoichiometric model with
inhibitory constraints. Representation of inhibition in the CBM
framework has always been a challenge, with proposed solutions
generally being computationally expensive methods based on
MILP.30 We have extended the approach of Vardi and colleagues31
and represented inhibition by linear constraints, enforcing a
reciprocal relation between inhibitor production and inhibited
ﬂux. Differences between the original formulation and our
Table 1. Summary of simulation formalisms applied in Use Cases
Use Case Formalisms Reference
Use Case 1: linear inhibitory constraints CBM, logical hypergraph, inhibitor and activator constraints This work
Use Case 2: integration of regulatory networks
and GSMNs
CBM, ODE, Gillespie, physiological compartment models This work and ref. 9
Use Case 3: prediction of metabolic landscapes CBM, congruency approach to analysis of ~ omics data in the
context of GSMNs
This work and ref. 45
Abbreviations: CBM, constraint-based modeling; GSMN, Genome-Scale Metabolic Network; ODE, Ordinary Differential Equation.
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extended implementation are presented as Supplementary
Information. An example of the logical hypergraph conversion
to MUFINS reaction formulas is shown in Figure 2. At the software
level this is achieved by exporting CellNetAnalyzer logical rules as
a text format and then using the text-replace function in Excel to
change the formula format and create a MUFINS reaction table
that can be opened by the JyMet GUI. We note these steps do not
require programming experience. Subsequently, the model was
edited in JyMet to deﬁne input ﬂuxes. Flux Variability Analysis was
undertaken to identify spurious activations in the model with all
input ﬂuxes constrained to 0. The details of these steps are given
in Supplementary Information (page 7), where we also compare
our model pre-processing steps with the much more complex,
MILP-based protocol used by Vardi et al.31
A unique feature of MUFINS is reconstruction of models that
combine GSMNs and regulatory networks with linear inhibitory
constraints. To demonstrate this capability we integrated the
signal transduction network model described above with the
published GSMN of the RAW264.7 macrophage cell line.29 We
have focused on nitric oxide production, a major metabolic
function of macrophages interacting with bacterial pathogens.
Our regulatory network model describes the regulation of the
inducible nitric oxide synthase (iNOS) gene, which we have
added as an activator for the NO synthase reaction in the GSMN
(reaction id: R_NOS2). We used a linear activator constraint, as
described in Supplementary Information (page 31), to ensure that
stoichiometry of the R_NOS2 reaction is not affected. Figure 3a
shows a portion of the total regulatory network, speciﬁcally the
immediate signaling pathways regulating iNOS gene expression.
We used this integrated model to simulate nitric oxide production
in response to lipopolysaccharide (LPS). Following Bordbar and
colleagues,29 we constrained biomass reaction ﬂux to 0.0281/h,
which reproduces experimentally measured growth rates. We
calculated the maximal extracellular nitric oxide production when
LPS input ﬂux to the regulatory network was opened or closed
and when phosphorylation of ERK by MEK1 was inhibited or not.
Results obtained from these four simulations are shown on
Figure 3b, and demonstrate that nitric oxide is produced only
when LPS activates the regulatory network, while the inhibitor
does not inﬂuence results. The maximal ﬂux through R_NOS
agrees with the value of 0.0399 mmol/gDW/h reported in original
publication, thus verifying SBML import of the GSMN model to
JyMet. We note that while in this Use Case, the regulatory network
regulates only one enzyme, this is an example of major global
Figure 2. The model of cell signaling, gene regulation and whole-cell metabolism in RAW264.7 macrophage. A signaling and gene regulatory
network of 286 interactions between 205 species, created in logical hypergraph formalism is shown. This network was subsequently
converted to FBA formalism with linear inhibitory constraints and coupled to the RAW264.7 GSMN through regulation of the iNOS gene. Nitric
oxide synthesis, a major metabolic ﬂux in RAW264.7 macrophages responding to a pathogen, was then simulated using constraints derived
from both stoichiometry of whole-cell metabolism and logical rules within a large-scale regulatory network. The inset shows the conversion of
logical hyperedges determining the fate of ifn_ab to reaction formulas with linear inhibitor constraint: For all reactions producing ifn_ab, the
molecule irf2 is added, preceded by the ‘~ ’ sign to indicate an inhibitor. This is parsed by MUFINS to mean that the reaction ﬂux is inhibited
(i.e., 0) if ifr2 is present. FBA, Flux Balance Analysis; GSMN, Genome-Scale Metabolic Network; iNOS, inducible nitric oxide synthase; MUFINS,
MUlti-Formalism Interaction Network Simulator.
Multi-formalism interaction network simulator
H Wu et al
4
npj Systems Biology and Applications (2016) 16032 Published in partnership with the Systems Biology Institute
metabolic reprogramming. The production of large amounts of
nitric oxide in response to pathogen requires both precursors and
energy, and the GSMN model accounts for stoichiometry of all
reactions linking medium nutrients to metabolic output. More-
over, the GSMN assures that the cell satisﬁes other metabolic
demands, such as the demand for biomass production whereby
the GSMN model accounts for global stoichiometry of providing
cellular components and maintaining energy during induced nitric
oxide production.
To compare the model predictions with the experimental data,
we treated RAW264.7 macrophages with LPS and a MEK inhibitor
and measured nitrate concentration in the medium. As nitrate can
be produced only by the non-enzymatic conversion of nitric oxide
from cells, and there is no nitrate consumption in the medium,
concentrations are proportional to the nitric oxide production ﬂux.
Figure 3c shows that the model correctly predicts that LPS is
obligate for the production of nitric oxide in RAW264.7 macro-
phages. However, the model did not predict the decrease in nitric
Figure 3. Mechanistic interpretation of experimental data on perturbation of whole-cell metabolic function by signaling network input and
inhibitor. MUFINS was used to integrate a genome-scale metabolic model of the mouse macrophage (RAW264.7) with a large-scale regulatory
network. Perturbation of whole-cell metabolism was simulated through activation and inhibition of the signaling network with external
production of nitric oxide set as the objective function. Predicted data was then compared with the experimental data. (a) The left panel
shows a screenshot of the JyMet interface, demonstrating on screen visualization of the reconstruction, created by automatic hierarchical
layout with manual adjustment. Hatched lines are used to indicate regulatory signals, representing inhibition (circle end) or stimulation (arrow
head). The right panel is a manually created image representing the pathway examined through JyMet; arrows represent signal ﬂux, while
open and ﬁlled circles represent inhibition and stimulation, respectively. The visualization depicts where signaling pathways converge on the
iNOS gene, which is required for nitric oxide (NO) production in the whole-cell stoichiometric model. Flux rates for an example FBA solution
are displayed on the network diagram; on the right panel only ﬂux rates for each transitions are presented for clarity, while the left panel also
shows the contribution of each substance to the ﬂux. (b) The original reconstruction was able to predict the increase in NO production
following stimulation with LPS, but not the impact of a MEK inhibitor, when compared with the experimental data of nitrate levels in
RAW264.7 cell-conditioned medium (c). Nitrate can only be produced by non-enzymatic conversion of NO produced by RAW264.7 cells, and as
there is no nitrate consumption in the medium, nitrate concentrations are proportional to nitric oxide production ﬂux. (d) Reﬁnement of the
signaling network led to agreement between in silico prediction and in vitro measurement. The reﬁnement was based upon two mechanistic
hypotheses: (i) ERK1/2 is a more potent transcriptional activator of the iNOS gene than JNK and HIF1, and (ii) MEK1 is a more potent ERK1/2
kinase than PKC. FBA, Flux Balance Analysis; iNOS, inducible nitric oxide synthase; LPS, lipopolysaccharide; MUFINS, MUlti-Formalism
Interaction Network Simulator; QSSPN, Quasi-Steady State Petri Net.
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Figure 4. Multi-formalism simulation integrating cortisol signaling with the human Recon2 GSMN reveals a drug interaction with estradiol
clearance. (a) The Petri Net diagram of network connectivity created in the Snoopy editor, with overlaid comments for clarity. Color and
symbol size has been manually set to match SBGN molecule types and transition types speciﬁc to QSSPN. The PN connectivity to implement a
timer for administering a network perturbation (cortisol burst), is contained within a coarse transition and shown as an insert. (b) Simulation
of glucose and lactate dynamics in the blood physiological compartment, demonstrating a convergence to physiologically realistic steady
states. Perturbation of the system through a simulated cortisol infusion starting after 500 min elicits a dynamic alteration in the signaling
network, resulting in (c) a predicted increase in CYP34A protein levels, which is conﬁrmed in primary human hepatocytes. The increased
expression of CYP3A4 protein is predicted to increase ﬂux through reactions catalyzed by this enzyme, leading to: (d) degradation of excess
cortisol and establishment of new steady state; (e) a drug–drug interaction for a second CYP3A4 substrate (estradiol), contained within the
GSMN, leading to a decrease in it’s steady-state level. The predicted increase in CYP3A4 activity following cortisol exposure is conﬁrmed in
primary human hepatocytes (f), as is the enhanced rate of estradiol clearance (g). FBA, Flux Balance Analysis; GSMN, Genome-Scale Metabolic
Network; mRNA, messenger RNA; QSSPN, Quasi-Steady State Petri Net. **Po0.01, ***Po0.001.
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oxide production caused by MEK inhibition. To explore this
inconsistency, we used the interactive network visualization
available in JyMet (Figure 3a) to examine example FBA solutions.
Multiple pathways lead to iNOS activation, some of which are not
dependent on MEK. In the model, the ‘iNOS’ substance
representing activity of the iNOS gene is produced by three
reactions representing the activity of ERK1/2-, HIF1- and
JNK-dependent regulation of iNOS gene expression. Each of these
regulators is, activated by different upstream signaling cascades.
We used JyMet to interactively simulate and visualize different
scenarios and concluded that the experimental results can be
replicated if the following assumptions are made: (i) ERK induces a
more potent activation of the iNOS gene than JNK and HIF1
(ii) MEK1 is a more potent ERK kinase than PKC. These assumptions
were introduced to the model by setting ﬂux bounds of (0, 0.005)
for the transitions ‘JNK-4 iNOS’, ‘HIF1-4iNOS’ and
‘PKC_a_b= ERK1/2’ (Figure 3a, right panel). The upper bound is
arbitrary, and selected to ensure that the ﬂux towards ‘iNOS’ via
‘HIF1’ or ‘JNK’ reaches only a fraction of value required for maximal
activation of R_NOS, with the remaining activation occurring via
ERK1/2 regulation. This reﬁned model is now able to reproduce
the decreased, but not complete inhibition, of nitric oxide
production by a MEK inhibitor (Figure 3d). A full description
of this cycle of prediction, experimental testing and model
reﬁnement is presented as Supplementary Information (page 11),
detailing how MUFINS and JyMet aid the iterative reﬁnement cycle
required during model development. These data support the
assumptions above being one possible mechanistic solution to
reproduce the observed biological phenotype. However, we note
that further experimental conﬁrmation is required to conﬁrm the
predicted biological insight. In a full iterative cycle of prediction,
experiment and model reﬁnement, multiple molecular targets
would be subject to independent experiment veriﬁcation before
the model was validated. Here, we show one full cycle of
simulation and experiment to demonstrate how the JyMet
interface is used in this iterative model development process.
To summarize, we present the ﬁrst linear model for steady-state
simulation of networks integrating signaling, gene regulation and
whole-cell metabolism in a mammalian cell. Moreover, we present
the ﬁrst simulation of perturbation of a global metabolic output by
a signaling network inhibitor, and demonstrate this is consistent
with experimental data. The ability to formulate hypotheses in
terms of continuous ‘regulatory strength’ is demonstrated. This
offers signiﬁcant advantages over MILP-based approaches such as
SR-FBA,32 where the regulatory network is used exclusively to
formulate Boolean, on/off constraints. Finally, the graphics user
interface JyMet allows an interactive exploration of combined
signaling and metabolic ﬂux distributions that is easily approach-
able by non-specialists. Together, these tools provide an ideal
platform for non-specialists to generate mechanistic hypotheses
based upon the interaction of gene and signal regulatory
networks with genome-scale metabolism. These hypotheses can
then drive experimental testing, enhancing our ability to identify
novel biological insights.
Use Case 2: kinetic model of cortisol signaling integrated with
dFBA simulation of human GSMN
An important challenge in computational biology is the
generation of large-scale models that are able to reproduce
diverse biological functions. One approach to achieve this aim is
the integration of validated small models (or modules) to form
larger networks. A major consideration in such integration is the
ability to combine models across different modeling formalisms
and biological scales. In this Use Case, we demonstrate the
utility of MUFINS for the generation and simulation of such
multi-formalism, multi-scale models.
Cortisol acts as an important signaling molecule within the
body, with roles in circadian biology and the response to stress
episodes. The level of cortisol in the body is interpreted at the
cellular level through interaction with three nuclear receptors:
the glucocorticoid receptor; the mineralocorticoid receptor; the
pregnane-X receptor. These signals are integrated and produce a
global metabolic shift corresponding to the current cortisol level.
To reproduce such a complex biological phenomenon, it is
necessary to combine multiple signaling cascades with genome-
scale reconstructions of metabolism. Here, we demonstrate the
application of MUFINS for such a multi-formalism simulation,
integrating a detailed kinetic model of cortisol signaling in the
liver, a genome-scale model of liver metabolism, and an ODE
model of glucose and lactate dynamics in the blood (Figure 4).
This is the ﬁrst simulation integrating a human GSMN,
physiological level ODE model and detailed kinetic model of an
intracellular regulatory network. Thus, this Use Case demonstrates
that MUFINS provides a unique tool for the integration of PBPK
models with the mechanistic models of molecular networks
operating in mammalian tissues.
The model is depicted in Figure 4a. We represent our previously
published kinetic model of cortisol signaling in liver33,34 as a
Petri net (PN) using Snoopy software.25 Size and color of
place/transition symbols was used to mirror Systems Biology
Graphical Notation35 molecule types as well as QSSPN speciﬁc
place/transition types. The PN transition rates were deﬁned using
the ODE terms of the kinetic model. The PN places represent
molecular concentrations. This dynamic model of cortisol
signaling was linked to the human GSMN Recon2, with the
CYP3A4 enzyme used as the QSSPN constraint place. The details of
the cortisol signaling model and its coupling to GSMN are
available in Supplementary Information (page 16).
To model whole-cell metabolism of hepatocytes, we used the
community-based Recon2 GSMN.36 This model incorporates liver-
speciﬁc reactions from the HepatoNet1,37 but is a much more
extensive reconstruction of cellular metabolism. Exchange ﬂuxes
were constrained using the HepatoNet1 Physiological Import and
Export set. The objective function was set to glucose regeneration
from lactate, a major physiological function of the liver, where
blood glucose and lactate concentrations are ODE variables. The
dFBA simulation is implemented using place and transition within
the QSSPN, rather than coded as a separate approach. We have
further capitalized on the ﬂexibility of the PN representation to
create a timer administering a cortisol infusion after 500 min. This
demonstrates how multi-formalism simulations in MUFINS can
include complex, time-dependent perturbations to the model
such as boluses or cell division events. For clarity, the timer is
contained within a coarse transition, with the sub-level shown as
an inset to Figure 4a. A detailed description of QSSPN place and
transition types is given as Supplementary Information (page 27),
along with a detailed description of model construction (page 12).
Simulations of the systems response to cortisol infusion, plus
experimental conﬁrmation are shown in Figures 4b–g. As shown
in Figure 4b, the glucose and lactate concentrations converge to
their physiological levels of 4.45 and 1.48 mM, respectively38 and
are maintained during cortisol infusion from 500 min onwards.
Cortisol infusion from 500 min produces a number of effects,
which are mediated through activation of the two cognate nuclear
receptors for cortisol within the regulatory network, PXR and
GR.39,40 The cortisol-mediated activation of PXR results in a
predicted increase in expression of the CYP3A4 enzyme
(Figure 4c), which is experimentally conﬁrmed at the transcript,
protein and activity levels in vitro using primary human
hepatocytes (Figure 4d). CYP3A4 is one of the main enzymes
responsible for the metabolic clearance of cortisol; thus, the
combination of a constant infusion of cortisol, followed by
increased metabolism, results in an elevated blood cortisol level
(Figure 4e). We note that the transition to this new blood cortisol
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level is not instant, demonstrating a concentration spike
consistent with the time delay caused by the de novo production
(i.e., transcription and translation) of CYP3A4 protein. Finally, in
Figure 4f, we demonstrate that the cortisol infusion propagates
through the signaling and metabolic networks, leading to
predicted changes in blood concentrations for other chemicals.
Estradiol is an endogenous hormone important in a range of
biological functions, including development of the secondary
sexual organs in both sexes and proliferation during the menstrual
cycle and pregnancy in women.41,42 It has considerable clinical
application, most notably as a contraceptive, either as the native
compound or synthetic derivatives.43 As shown in Figure 4e,
following the cortisol infusion, predicted levels of blood estradiol
drop rapidly, decreasing approximately by one-half within
500 min. This lower level is maintained throughout the period
where CYP3A4 protein levels are elevated. To conﬁrm this effect,
we have measured the clearance rate for estradiol in naive primary
human hepatocytes and compared it with hepatocytes
pre-exposed to 1μM cortisol, demonstrating enhanced clearance
in cortisol-exposed hepatocytes (Figure 4g). In addition, we note
that activation of PXR has previously been linked with a number
of drug–drug interactions with estrogens, demonstrating the
extrapolation of these predictions to the clinical setting.40,44
It is important to note that estradiol concentration was not a
variable of the detailed kinetic model, and was rather identiﬁed as
a variable of interest by examination of perturbed GSMN ﬂuxes.
This demonstrates how integration of detailed kinetic models with
GSMNs can lead to the identiﬁcation of interactions of biological
interest. As such, this approach has much potential for
the prediction of clinically relevant drug-induced disruption of
homeostasis, and drug–drug interactions.40,44
In summary, this Use Case demonstrates the utility of MUFINS to
combine legacy models developed in different formalisms
and link molecular network knowledge to quantitative data
on substance concentration at physiological level. As such,
MUFINS represents the ﬁrst software to allow such multi-scale,
multi-formalism simulations through a GUI approachable to the
non-specialist.
Use Case 3: analysis of a clinical transcriptome data to understand
in vivo tumor metabolism
An important branch of CBM methodology5 is dedicated to using
~ omics data to create tissue and/or condition speciﬁc GSMNs.
MUFINS is equipped with state-of-the-art CBM methods in this
area; in addition, we have developed Fast iMAT, a new variant of
the iMAT approach that is applicable to large ~ omics sample
numbers, where iMAT becomes impractical. We recently reported
a preliminary version of Fast iMAT,45 dedicated to the analysis of
expression data discretized to two states (absent or present
transcript). Personalized GSMNs for 2,000 breast tumors were
generated, identifying a low prognosis cluster with active
serotonin production—an important biological insight.45 The ﬁrst
distribution version of MUFINS provides a mature version of the
Fast iMAT algorithm. To demonstrate its utility, we analyze 262
previously unexamined paired clinical transcriptome samples.46
We demonstrate the signiﬁcant upregulation of kyneurenine
synthesis in tumor compared with normal breast tissue, and
important pro-survival phenotype.47,48
COMPARISON OF MUFINS WITH EXISTING TOOLS
A comparison of MUFINS with existing tools is presented as
Supplementary Information. We conclude that MUFINS is currently
the only software supporting integration of (i) exact stochastic,
(ii) ODE, (iii) qualitative dynamic, (iv) logical steady state and
(v) CBM models in a general software platform with GUI. The only
alternative to achieve integration of this range of formalisms is
coding of the model in mathematical modeling environment.
Although this strategy has achieved success,13 it is not a plausible
proposition for non-specialists who lack programming skills.
Moreover, multi-formalism modeling in a mathematical language
involves the implementation of a simulation algorithm dedicated
to each model. In MUFINS, each model is run in the same QSSPN
simulation algorithm, with multi-formalism functionality emerging
from the interactions between the different types of Petri Net
places and transitions that can be graphically assembled, leading
to a combinatorial diversity of types of models that can be
simulated. Using one algorithm and a few well-deﬁned place and
transition types provides clearer control and description of model
assumptions than coding a different main simulation loop for each
model. Also, the algorithms available in MUFINS are validated and
optimized against the legacy of previous applications, while
formulation, validation and description of a simulation algorithm
dedicated to a particular model will take additional time. It is our
experience that even scientists who can program will ﬁnd it easier
to implement complex multi-formalism models by connecting
QSSPN places and transitions to off-the-shelf GSMN models
imported to JyMet, rather then by the development of dedicated
mathematical modeling code. Moreover, MUFINS provides a wide
range of CBM methods that can be used to model GSMNs before
their integration with dynamic models. As Supplementary
Information, we perform the largest review of CBM methods
conducted to date (165 methods and 30 software packages),
demonstrating that MUFINS is the second most general CBM
software after COBRA toolbox49 in terms of the number of
methods implemented. However, it provides the largest number
of CBM methods under GUI with interactive network visualization.
Finally, all CBM methods can now be applied to models
formulated with inhibitor and activator constraints, which again
enables execution of new CBM protocols without the need of
coding (e.g., iMAT applied to models involving steady-state
regulatory network).
FUTURE DIRECTIONS
We will continue to develop MUFINS towards improved inter-
operability with other tools and model databases, a key for model
integration. Although currently QSSPN can be simulated only in
MUFINS, deﬁnition of this multi-formalism framework in SBML will
motivate the development of alternative tools. As shown in
Figure 1, QSSPN models can currently be exported into two
separate SBML ﬁles representing the CBM and PN parts of the
model. We intend to represent QSSPN lookup tables, reset
transitions and ﬂux monitors with existing SBML objects, or to
develop a bespoke SBML package. Furthermore, we will work
towards improving integration of SBML ﬁles imported from public
repositories into multi-formalism models in the JyMet GUI.
This will involve further work on network visualization in JyMet,
providing a graph editor dedicated to connecting different
mechanistic models by common variables. We also plan to
develop interoperability between MUFINS and Garuda
(http://www.garuda-alliance.org) to make full use of our
multi-formalism simulation tool within this established alliance
of systems biology software. This will be facilitated by design of
our software (Figure 1) providing stand-alone simulation engines
ideal for embedding in different interfaces.
Conclusions
The multi-scale nature of complex biological systems is
currently the major challenge preventing their computational
understanding. A number of theoretical frameworks have
achieved spectacular successes in mechanistically modeling
different levels of cellular organization such as metabolic,
signaling and gene regulatory networks. However, in a real cell,
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all these processes proceed simultaneously, and without multi-
scale simulation the insight and predictive power provided by
models will be limited. We present MUFINS, the ﬁrst general
software addressing this multi-formalism simulation challenge.
Novel algorithms available in MUFINS provide solutions for three
major technological challenges: (i) integration of CBM and hybrid
stochastic/deterministic dynamic simulation; (ii) CBM of integrated
signaling/metabolic models; (iii) analysis of large clinical tran-
scriptome studies in the context of GSMN. This is demonstrated
through three Use Cases, where we simulate models of
mammalian systems composed of: GSMNs, logical hypergraph
models of signaling, kinetic models of gene regulation and PBPK
models. We experimentally validate model predictions and show
how our software can aid experimental scientists through an
iterative cycle of hypothesis generation, experimentation and
model reﬁnement. Because the need for a multi-scale, multi-
formalism approach is currently most recognized in the context of
Personalized Medicine and Quantitative Systems Pharmacology,
we focused our Use Cases on mammalian cells. However,
mechanistic simulation is a major tool in Synthetic Biology, where
MUFINS will be ideal to integrate detailed models of genetic
circuits with GSMNs and further extend molecular cell factory
models to include bioreactor mass transfer. Therefore, we believe
that multi-formalism simulation with MUFINS will ﬁnd broad
application in mechanistic modeling of biological systems.
Software availability
MUFINS is free, open source software available under GNU GPL
license from:
MUFINS home page: http://sysbio3.fhms.surrey.ac.uk/muﬁns/
GitHub repository: https://github.com/kierzek/MUFINS
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